Acute pancreatitis associated with levofloxacin.

Area of Science:

• Pharmacology
• Gastroenterology
• Clinical Medicine

Background:

• Drug-induced acute pancreatitis is a recognized clinical concern.
• Antibiotics, including fluoroquinolones, have been implicated in pancreatitis.
• Levofloxacin's safety profile includes potential gastrointestinal adverse effects.

Purpose of the Study:

• To highlight levofloxacin as a potential cause of acute pancreatitis.
• To inform healthcare providers about this specific adverse drug reaction.
• To contribute to the pharmacovigilance of levofloxacin.

Main Methods:

• Literature review of case series reporting drug-induced pancreatitis.
• Analysis of safety data sheets for levofloxacin.
• Review of existing medical literature on fluoroquinolone-associated pancreatitis.

Main Results:

• Drug-induced acute pancreatitis accounts for 0.3-1.5% of all acute pancreatitis cases.
• Levofloxacin is explicitly listed as a causative agent in its safety data sheet.
• This finding aligns with known adverse effects of fluoroquinolone antibiotics.

Conclusions:

• Levofloxacin represents a specific drug-induced cause of acute pancreatitis.
• Awareness of this adverse effect is crucial for early diagnosis and management.
• Pharmacovigilance efforts should continue to monitor antibiotic-related pancreatitis.